# INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus

> **NCT01367457** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 243 (actual)

## Conditions studied

- Carcinoma, Renal Cell
- Lymphoma, Mantle-Cell

## Interventions

- **OTHER:** Temsirolimus (Non-Interventional Study)

## Key facts

- **NCT ID:** NCT01367457
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 243 (ACTUAL)
- **Last updated:** 2016-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01367457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01367457, "INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01367457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*